Inhibition of RNA polymerase I transcription activates targeted DNA damage response and enhances the efficacy of PARP inhibitors in high-grade serous ovarian cancer. Conference Paper uri icon

authors

  • Sanij, Elaine
  • Hannan, Katherine
  • Xuan, Jiachen
  • Yan, Shunfei
  • Ahern, Jessica A
  • Trigos, Anna S
  • Brajanovski, Natalie
  • Son, Jinbae
  • Chan, Keefe T
  • Kondrashova, Olga
  • Lieschke, Elizabeth
  • Wakefield, Matthew J
  • Ellis, Sarah
  • Cullinane, Carleen
  • Poortinga, Gretchen
  • Khanna, Kum Kum
  • Mileshkin, Linda
  • McArthur, Grant A
  • Soong, John
  • Berns, Els M
  • Hannan, Ross D
  • Scott, Clare L
  • Sheppard, Karen E
  • Pearson, Richard B

publication date

  • July 1, 2020